← Eichor
Study identifier: NCT07176767 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

The IPAD Cohort Study: Insomnia and Positive Airway Pressure Adherence in Children and Adolescents

Condition: Sleep Apnea, Obstructive · Insomnia  ·  Sponsor: Lena Xiao

PhaseN/A
Planned participants82
Who can joinAll sexes, 8 Years to 18 Years
Healthy volunteersNo

About this study

Positive Airway Pressure (PAP) is a treatment used to help people with sleep-disordered breathing, particularly those with obstructive sleep apnea (OSA). The device delivers pressurized air through a mask to keep the airways open during sleep, improving breathing and preventing interruptions in sleep. Studying how insomnia affects PAP adherence in children can help improve future treatments. However, no long-term studies have looked at this in children. Based on previous research, the investigators plan to conduct a study across multiple centers focusing on children with OSA starting PAP therapy. The study will explore how insomnia affects PAP adherence and how race and ethnicity play a role.

This description comes directly from the study's public registry record.

Talk to the study team

Lena J Xiao, MD MSc  ·  6048752345  ·  lena.xiao@cw.bc.ca

Macyn LY Leung, MSc  ·  6048752345  ·  macyn.leung@bcchr.ca

Always discuss trial participation with your own doctor first.

Locations (1)

British Columbia Children's HospitalVancouver, British Columbia, CanadaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07176767